Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties.
about
Tetrastatin, the NC1 domain of the α4(IV) collagen chain: a novel potent anti-tumor matrikine.Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.Extracellular matrix modulates angiogenesis in physiological and pathological conditions.Regulation of Tumor Angiogenesis and Choroidal Neovascularization by Endogenous Angioinhibitors.Reclaiming a natural beauty: whole-organ engineering with natural extracellular materialsAnti-angiogenic peptides for cancer therapeuticsA biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer.Structure-activity relationship study of collagen-derived anti-angiogenic biomimetic peptidesCollagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells.Type IV collagen is a tumour stroma-derived biomarker for pancreas cancerSynergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.Matricryptins and matrikines: biologically active fragments of the extracellular matrix.Anti-angiogenic peptides identified in thrombospondin type I domains.Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cellsEndogenous Matrix-Derived Inhibitors of Angiogenesis.
P2860
Q31058993-330F1165-8CBA-4B7F-B0AD-15A6C76C90DFQ33528171-5FF8B6F3-7F32-4FE4-BBE1-C2F1D24F39AEQ33737210-C871D15E-69C7-453D-A105-4A867DFFBD61Q34230899-351F9CFE-0A30-41BA-8856-D2A166F7E934Q35003620-7F94B021-0DBD-49C1-A65D-59F8349DC252Q35043016-E834F73B-CC73-4C10-952E-71D23877CA5DQ35407573-8FCFD0F5-2A29-486D-8919-93294CA62996Q36020002-EB2D013E-312F-4F6D-8ED3-299E54FD709AQ36062996-FDAE03A8-0F4C-45E6-AFF9-96CB789719C0Q36893507-E70B32D6-4102-42E8-B96D-6EF6CD0D9CB6Q37269683-9D674724-674C-4C4B-8964-61F563AE110DQ37401441-424C79F2-3069-4C65-B0CF-C10FD39FA6C0Q37478620-A9A07EA0-1806-4CFD-B25A-5C99D09B1798Q38210749-927E7553-E3DA-4E70-83C1-2CDE7E2D0DA6Q42089006-EFFCE017-7117-4A04-9ABF-351526E3728AQ42750998-5DDDC68B-B9A6-4221-A2E5-658A4FBEF301Q55506580-2B845CAB-302E-4AA4-8BA4-9FA611A16B4A
P2860
Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Identification of novel short ...... th anti-angiogenic properties.
@en
Identification of novel short ...... th anti-angiogenic properties.
@nl
type
label
Identification of novel short ...... th anti-angiogenic properties.
@en
Identification of novel short ...... th anti-angiogenic properties.
@nl
prefLabel
Identification of novel short ...... th anti-angiogenic properties.
@en
Identification of novel short ...... th anti-angiogenic properties.
@nl
P2860
P1476
Identification of novel short ...... th anti-angiogenic properties.
@en
P2093
Emmanouil D Karagiannis
P2860
P304
P356
10.1016/J.BBRC.2006.12.231
P577
2007-01-16T00:00:00Z